Immatics (IMTX) director receives grant of 48,000 stock options at $9.09

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Immatics N.V. director Michael G. Atieh received a grant of stock options covering 48,000 underlying ordinary shares. The options have an exercise price of $9.09 per share, expire on June 15, 2036, and vest 100% on the first anniversary of the June 16, 2025 grant date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider ATIEH MICHAEL G

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	48,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 48,000 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Option grant size: 48,000 options Exercise price: $9.09 per share Total options after grant: 48,000 options +3 more

6 metrics

Option grant size 48,000 options Stock Option (Right to Buy) covering ordinary shares

Exercise price $9.09 per share Exercise price for underlying ordinary shares

Total options after grant 48,000 options Total derivative securities following transaction

Vesting date June 16, 2026 Options vest 100% on first anniversary of grant

Expiration date June 15, 2036 Option expiration for this grant

Transaction code A Grant, award, or other acquisition of derivatives

Key Terms

Stock Option (Right to Buy), Ordinary Shares, exercise price, Grant, award, or other acquisition, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Ordinary Shares financial

"underlying_security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"conversion_or_exercise_price: "9.0900""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

vest 100% financial

"These Options vest 100% on the first anniversary of the grant date"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/18/2026 - 04:47 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ATIEH MICHAEL G

(Last)

(First)

(Middle)

PAUL-EHRLICH-STR. 15

(Street)

TUBINGEN

72076

(City)

(State)

(Zip)

GERMANY

(Country)

2. Issuer Name and Ticker or Trading Symbol
Immatics N.V. [ IMTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$9.09	06/16/2026		A		48,000		⁽¹⁾	06/15/2036	Ordinary Shares	48,000	$0	48,000	D

Explanation of Responses:

1. These Options vest 100% on the first anniversary of the grant date, June 16, 2026.

	/s/ Edward Sturchio, attorney-in-fact for Michael G. Atieh	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Immatics (IMTX) director Michael G. Atieh report on this Form 4?

Michael G. Atieh reported receiving a grant of stock options for 48,000 ordinary shares of Immatics N.V. These options are a compensation-related award, not an open-market purchase or sale, and give him the right to buy shares at a fixed exercise price.

How many Immatics (IMTX) stock options were granted to the director?

The director received options for 48,000 underlying ordinary shares of Immatics N.V. This entire amount is reflected as the total derivative position following the transaction, indicating the full grant size recorded in this filing for the reported award.

What is the exercise price of the Immatics (IMTX) options granted?

The stock options have an exercise price of $9.09 per ordinary share. This means the director can buy Immatics shares at $9.09 regardless of future market price, once the options are vested and before they expire.

When do the Immatics (IMTX) options granted to the director vest?

According to the footnote, the options vest 100% on the first anniversary of the grant date, June 16, 2026. Until vesting, the director cannot exercise these options to purchase Immatics ordinary shares at the stated exercise price.

When do the Immatics (IMTX) director stock options expire?

The stock options are scheduled to expire on June 15, 2036. After this expiration date, any unexercised options will lapse and can no longer be used to buy Immatics ordinary shares, even if they were previously vested and exercisable.

Is this Immatics (IMTX) Form 4 a market buy or sell of shares?

This Form 4 reflects a grant of stock options as compensation, not a market buy or sell. The transaction code "A" indicates an award or other acquisition, and no open-market purchase or sale of Immatics ordinary shares is reported here.